The three genes that were most strongly upregulated by SSA/DA treatment in somatotropinoma tissues were MPPED1, TMEM132C, and SEPTIN14, potentially having more indirect evidence for their involvement in anti-tumor effect. This evidence concerns the gene SEPTIN14 and growth hormone-producing pituitary gland neoplasm.